May 11, 2021
| By Gayle Gerling Pettinga
| Read Time: < 1 minute
A recent study out of Canada highlights the lack of advancement in treatment for pleural mesothelioma.
Diagnosis with the cancer, caused by exposure to asbestos, typically leads to survival expectancies of nine to 10 months. Treatment to extend survival time is a main advancement the study shows has not come to fruition.
The study reviewed three types of treatment for mesothelioma:
- Indwelling pleural catheters,
- Chemotherapy, and
While the study determined a lack of advancement in these treatment methods, it also stated that immunotherapy could be a promising future treatment.
Born and raised in Evansville, Gayle is a respected, experienced lawyer and a valued community leader. She graduated near the top of her class at Indiana University’s prestigious Maurer School of Law. She’s practiced law with one of the largest firms in Indianapolis as well as one of the largest pharmaceutical companies in the world. And that means she knows how big law firms and big companies think and how they operate – and she will put that knowledge to work for you.
Gayle has received numerous awards and honors including Martindale-Hubbell — Peer Review Rated: AV®, American Institute of Personal Injury Attorneys 10 Best Attorneys in Indiana for Exceptional and Outstanding Client Service, and YWCA Evansville 100 Years, 100 Women Honoree, 2011.